Profound Medical Corp.

Toronto Stock Exchange PRN.TO

Profound Medical Corp. Market Capitalization on January 14, 2025: USD 217.96 M

Profound Medical Corp. Market Capitalization is USD 217.96 M on January 14, 2025, a 28.66% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Profound Medical Corp. 52-week high Market Capitalization is USD 267.68 M on July 26, 2024, which is 22.81% above the current Market Capitalization.
  • Profound Medical Corp. 52-week low Market Capitalization is USD 157.65 M on May 01, 2024, which is -27.67% below the current Market Capitalization.
  • Profound Medical Corp. average Market Capitalization for the last 52 weeks is USD 197.98 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Toronto Stock Exchange: PRN.TO

Profound Medical Corp.

CEO Dr. Arun Swarup Menawat MBA, Ph.D.
IPO Date July 10, 2018
Location Canada
Headquarters 2400 Skymark Avenue
Employees 131
Sector Health Care
Industries
Description

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Similar companies

MDNA.TO

Medicenna Therapeutics Corp.

USD 0.91

-2.78%

HLS.TO

HLS Therapeutics Inc.

USD 2.70

2.33%

StockViz Staff

January 15, 2025

Any question? Send us an email